SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 75 filers reported holding SOLID BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $36,000 | -34.5% | 29,604 | -6.6% | 0.00% | – |
Q4 2021 | $55,000 | -29.5% | 31,687 | -2.9% | 0.00% | – |
Q3 2021 | $78,000 | -36.1% | 32,635 | -2.3% | 0.00% | – |
Q2 2021 | $122,000 | +34.1% | 33,411 | +103.9% | 0.00% | – |
Q1 2021 | $91,000 | -26.6% | 16,387 | +0.3% | 0.00% | – |
Q4 2020 | $124,000 | +313.3% | 16,343 | +10.6% | 0.00% | – |
Q3 2020 | $30,000 | -31.8% | 14,780 | -2.2% | 0.00% | – |
Q2 2020 | $44,000 | +57.1% | 15,116 | +29.9% | 0.00% | – |
Q1 2020 | $28,000 | -49.1% | 11,634 | -5.5% | 0.00% | – |
Q4 2019 | $55,000 | -57.0% | 12,307 | -0.8% | 0.00% | -100.0% |
Q3 2019 | $128,000 | +132.7% | 12,410 | +29.0% | 0.00% | – |
Q2 2019 | $55,000 | -23.6% | 9,621 | +23.8% | 0.00% | – |
Q1 2019 | $72,000 | -66.5% | 7,772 | -3.1% | 0.00% | -100.0% |
Q4 2018 | $215,000 | -43.6% | 8,024 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $381,000 | +80.6% | 8,085 | +36.3% | 0.00% | 0.0% |
Q2 2018 | $211,000 | +379.5% | 5,931 | +2.2% | 0.00% | – |
Q1 2018 | $44,000 | – | 5,803 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,989,444 | $53,317,000 | 18.22% |
Boxer Capital, LLC | 3,498,272 | $93,754,000 | 11.58% |
RA Capital Management | 2,689,444 | $72,077,000 | 4.20% |
Perceptive Advisors | 3,927,222 | $105,249,000 | 4.01% |
EcoR1 Capital, LLC | 867,246 | $23,242,000 | 2.33% |
EMORY UNIVERSITY | 68,714 | $1,842,000 | 1.45% |
Cormorant Asset Management, LP | 652,987 | $17,500,000 | 1.42% |
PFM Health Sciences, LP | 1,335,080 | $35,780,000 | 0.95% |
Foresite Capital Management III, LLC | 98,942 | $2,652,000 | 0.87% |
ARMISTICE CAPITAL, LLC | 332,000 | $8,898,000 | 0.67% |